Carmat S.A [ALCAR] vs Novacyt S.A [ALNOV] Detailed Stock Comparison
Carmat S.A
Euronext
Loading...
Novacyt S.A
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 17 vital metrics comparison: Carmat S.A wins in 5 metrics, Novacyt S.A wins in 11 metrics, with 0 ties. Novacyt S.A appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Carmat S.A | Novacyt S.A | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -0.11 | -0.80 | Novacyt S.A |
| Price-to-Book Ratio | N/A | 0.70 | N/A |
| Debt-to-Equity Ratio | -1.13 | 24.81 | Carmat S.A |
| PEG Ratio | -0.05 | 1.82 | Carmat S.A |
| EV/EBITDA | -1.23 | -1.31 | Novacyt S.A |
| Profit Margin (TTM) | -336.56% | -212.73% | Novacyt S.A |
| Operating Margin (TTM) | -644.75% | -84.87% | Novacyt S.A |
| Return on Equity | 100.52% | -57.28% | Carmat S.A |
| Return on Assets (TTM) | -64.45% | -10.19% | Novacyt S.A |
| Free Cash Flow (TTM) | $-44.82M | $-12.74M | Novacyt S.A |
| 1-Year Return | -94.83% | -59.48% | Novacyt S.A |
| Price-to-Sales Ratio (TTM) | 1.09 | 1.78 | Carmat S.A |
| Enterprise Value | $58.29M | $17.03M | Carmat S.A |
| EV/Revenue Ratio | 7.94 | 0.75 | Novacyt S.A |
| Revenue per Share (TTM) | $0 | $0 | Novacyt S.A |
| Earnings per Share (Diluted) | $-1.15 | $-0.64 | Novacyt S.A |
| Beta (Stock Volatility) | 1.37 | 0.10 | Novacyt S.A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Carmat S.A vs Novacyt S.A Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Carmat S.A | 4.21% | -29.41% | -60.00% | -85.54% | -86.36% | -89.29% |
| Novacyt S.A | 0.21% | 0.00% | 0.00% | -18.97% | -21.67% | -22.95% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Carmat S.A | -94.83% | -99.11% | -99.37% | -99.80% | -99.87% | -99.87% |
| Novacyt S.A | -59.48% | -56.48% | -86.05% | -88.99% | -94.46% | -94.46% |
Performance & Financial Health Analysis: Carmat S.A vs Novacyt S.A
| Metric | ALCAR | ALNOV |
|---|---|---|
| Market Information | ||
| Market Cap | €8.56M | €34.84M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 2,469,007 | 200,980 |
| 90 Day Avg. Volume | 1,398,367 | 181,413 |
| Last Close | €0.13 | €0.47 |
| 52 Week Range | €0.09 - €2.43 | €0.42 - €1.19 |
| % from 52W High | -94.71% | -60.22% |
| All-Time High | €159.25 (May 13, 2013) | €13.96 (Oct 26, 2020) |
| % from All-Time High | -99.92% | -96.63% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.13% | N/A |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | -3.37% | -2.13% |
| Operating Margin (TTM) | -6.45% | -0.85% |
| Return on Equity (TTM) | 1.01% | -0.57% |
| Debt to Equity (MRQ) | -1.13 | 24.81 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €-0.81 | €0.68 |
| Cash per Share (MRQ) | €0.11 | €0.43 |
| Operating Cash Flow (TTM) | €-43,311,000 | €-11,367,175 |
| Levered Free Cash Flow (TTM) | €-29,735,500 | €7.14M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Carmat S.A vs Novacyt S.A
| Metric | ALCAR | ALNOV |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -0.11 | -0.80 |
| Forward P/E | -0.05 | 1.82 |
| PEG Ratio | -0.05 | 1.82 |
| Price to Sales (TTM) | 1.09 | 1.78 |
| Price to Book (MRQ) | N/A | 0.70 |
| Market Capitalization | ||
| Market Capitalization | €8.56M | €34.84M |
| Enterprise Value | €58.29M | €17.03M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.94 | 0.75 |
| Enterprise to EBITDA | -1.23 | -1.31 |
| Risk & Other Metrics | ||
| Beta | 1.37 | 0.10 |
| Book Value per Share (MRQ) | €-0.81 | €0.68 |
Financial Statements Comparison: Carmat S.A vs Novacyt S.A
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ALCAR | ALNOV |
|---|---|---|
| Revenue/Sales | N/A | N/A |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | N/A | N/A |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ALCAR | ALNOV |
|---|---|---|
| Cash & Equivalents | €4.70M | €35.25M |
| Total Current Assets | €32.35M | €45.58M |
| Total Current Liabilities | €19.07M | €7.20M |
| Long-Term Debt | €55.51M | €12.29M |
| Total Shareholders Equity | €-51.13M | €55.43M |
| Retained Earnings | €-98.49M | €-13.54M |
| Property, Plant & Equipment | €21.28M | €0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ALCAR | ALNOV |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ALCAR | ALNOV |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 2,469,007 | 200,980 |
| Average Daily Volume (90 Day) | 1,398,367 | 181,413 |
| Shares Outstanding | 42.56M | 81.73M |
| Float Shares | 31.83M | 70.58M |
| % Held by Insiders | 0.25% | 0.00% |
| % Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Carmat S.A vs Novacyt S.A
| Metric | ALCAR | ALNOV |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |